ISSN: 1872-2148

Journal Home

Journal Guideline

Recent Patents on Endocrine, Metabolic and Immune Drug Discovery Q4 Unclaimed

Bentham Science Publishers B.V. United Arab Emirates

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Recent Patents on Endocrine, Metabolic and Immune Drug Discovery is a journal indexed in SJR in Medicine (miscellaneous) and Drug Discovery with an H index of 22. It has a price of 2160 €. It has a best quartile of Q4.

Type: Journal

Type of Copyright:

Languages:

Open Access Policy:

Type of publications:

Publication frecuency: -

Categories: Biochemistry (medical) (Q4) Drug Discovery (Q4) Endocrinology, Diabetes and Metabolism (Q4) Immunology and Allergy (Q4) Medicine (miscellaneous) (Q4)

Price

2160 €

Inmediate OA

NPD

Embargoed OA

0 €

Non OA

Metrics

Recent Patents on Endocrine, Metabolic and Immune Drug Discovery

-

SJR Impact factor

22

H Index

0

Total Docs (Last Year)

8

Total Docs (3 years)

0

Total Refs

2

Total Cites (3 years)

7

Citable Docs (3 years)

0

Cites/Doc (2 years)

0.0

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

North Carolina Medical Journal Q4
European Journal of Mass Spectrometry Q4
Israel Medical Association Journal Q4
Neuroendocrinology Letters Q4
Medico-Legal Journal Q4

Compare this journals

Aims and Scope

Best articles by citations

Lysophosphatidic Acid and Renal Fibrosis

The Therapeutic Potential of Melatonin in Neurological Disorders

Pituitary Microadenoma Treated with Antipsychotic Drug Aripiprazole

Menstrual Cycle and Glycemic Control

Impaired Clearance of Neutrophils Extracellular Trap (NET) May Induce Detrimental Tissular Effect

Meet Our Editorial Board Member

Current Opinion in the Pharmaceutical Management of Irritable and Inflammatory Bowel Diseases: Role of ATP

Current and Future Development of Estrogen Receptor Ligands: Applications in Estrogen-Related Cancers

Is Innate Immunity and Inflammasomes Involved in Pathogenesis of Amyotrophic Lateral Sclerosis (ALS)?

Recent Patents and Developments in Glaucoma Biomarkers

Whole Organism Based Techniques and Approaches in Early Stage Oncology Drug Discovery-Patents and Trends

Pharmacoperones: A New Therapeutic Approach for Diseases Caused By Misfolded G Protein-Coupled Receptors

SHOW MORE ARTICLES

Novel Neuroendocrine and Metabolic Mechanism Provides the Patented Platform for Important Rejuvenation Therapies: Targeted Therapy of Telomere Attrition and Lifestyle Changes of Telomerase Activity with the Timing of Neuron-Specific Imidazole-Contain

The Regulatory Roles of Mitogen-Activated Protein Kinase (MAPK) Pathways in Health and Diabetes: Lessons Learned from the Pancreatic beta-Cell

Biochemical Markers of Bone Turnover and their Role in Osteoporosis Diagnosis: A Narrative Review

Recent Patents on Light Based Therapies: Photodynamic Therapy, Photothermal Therapy and Photoimmunotherapy

Biological Activities of Red Propolis: A Review

Meet Our Editorial Board Member:

MAVS: A New Weapon in the Fight Against Viral Infections

Meet Our Editorial Board Member:

Biology and Regulatory Roles of Nuclear Lamins in Cellular Function and Dysfunction

Recent Patents on the Treatment of Type 1 Diabetes

Current Pharmacological Approaches to Prevent and Treat Post- Menopausal Osteoporosis

Treatment of Anaplastic Thyroid Cancer: Is there a Role for PPARgamma Agonists?